TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With

Nigel H Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.